HomeMedical Devices

Medical Devices Market Research Reports & Consulting

discount on Mnm

Market Reports


Title Published Price TOC Available

Lancets Market by Type (Safety Lancets (Push button, Pressure Activated, Side Button), Personal Lancets), Application (Glucose Testing, Hemoglobin Testing), End User (Hospital, Clinic, Homecare), Region - Global Forecast to 2024

The lancets market is projected to reach USD 1,442 million by 2024 from USD 804 million in 2019, at a CAGR of 12.4% between 2019 and 2024. Growth in the lancets market is mainly driven by the growing prevalence of diabetes and the high prevalence of infectious diseases across the globe. Prominent players in the lancets market are Becton, Dickinson and Company (US), Roche Diagnostics (Switzerland), Ypsomed (Switzerland), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Own Mumford (UK), HTL-STREFA S.A (Poland), ARKRAY (Japan), Sarstedt (Germany), and SteriLance Medical (Suzhou) (China).

June 2019 $ 5650 selected

Bio Decontamination Market by Product (Equipment, Service, Consumables), Agent (Hydrogen Peroxide, Chlorine, Nitrogen, Peracetic Acid), Type (Room, Chamber), End User (Pharma, Biotech, Medical Devices, Hospital, Life Science) - Global Forecast to 2024

The bio Decontamination Market is projected to reach USD 175 million by 2024 from USD 130 million in 2019, at a CAGR of 6.1% from 2019 to 2024. Emerging economies are expected to provide a wide range of growth opportunities for players in the market. The major players operating in this market are STERIS (US), Ecolab, Inc. (US), TOMI Environmental Solutions, Inc (US), JCE Biotechnology (France), Fedegari Autoclavi SpA (Italy), Zhejiang Tailin Bioengineering Co., Ltd. (China), Noxilizer, Inc. (US), Howorth Air Technology Limited (UK), Wenzhou Weike Biological Laboratory Equipment Co., Ltd. (China), ClorDiSys Solutions Inc. (US), and Amira S.r.l. (Italy).

June 2019 $ 5650 selected

Catheter Stabilization Device/Catheter Securement Device Market by Product ((Arterial, CVS (Portal, Femoral), Chest, Epidural, Peripheral (Nasogastric, Endotracheal, Foley)), Application (Cardiovascular, Respiratory), End User - Global Forecast to 2024

The global catheter securement devices market is projected to reach USD 1.6 billion by 2024 from USD 1.1 billion in 2019, at a CAGR of 7.5% from 2019 to 2024. The emerging economies such as India and China are expected to provide a wide range of growth opportunities for players in the market which is driven by growing incidences of heart and other life style diseases. The major players operating in the catheter securement devices market are Baxter International, Inc. (US), and Cardinal Health (US), 3M Company (US), C. R. Bard, Inc. (US), B. Braun Melsungen AG (Germany), , ConvaTec Inc. (UK), Merit Medical Systems, Inc. (US), Smiths Group plc (UK), Centurion Medical Products (US), and M.C. Johnson Company, Inc. (US).

June 2019 $ 5650 selected

China Hemodialysis and Peritoneal Dialysis Market by Product & Services (HD, PD, Machine, Dialyzer, Concentrate, Dialysate, Catheter, Service), Modality (CAPD, APD, Nocturnal), End User (Hospital, Independent Center, Home Dialysis) - Forecast to 2024

The China hemodialysis and peritoneal dialysis market is projected to grow from an estimated USD 5.0 billion in 2019 to USD 7.4 billion by 2024, at a CAGR of 8.5% during the forecast period. Market growth is largely driven by factors such as increasing number of ESRD patients, growing prevalence of diabetes & hypertension (major causes of kidney failure), and preference for dialysis treatments over kidney transplants due to lack of donors. Furthermore, rise in the number of dialysis centers across China coupled with the increasing interest of market players to expand their network in the country through the acquisition of dialysis facilities is adding growth opportunities to China hemodialysis and peritoneal dialysis market. Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US) and Shandong Weigao Group Medical Polymer Company Limited (China) dominated the China hemodialysis and peritoneal dialysis market. Other players in this market include B. Braun Melsungen AG (Germany), Nikkiso Co. Ltd. (Japan), DaVita Healthcare Partners, Inc (US), Asahi Kasei Medical Co., Ltd (Japan), Bain Medical Equipment Co., Ltd. (China), Huaren Pharmaceutical (China), and Jiangsu Lengthen Life Science and Technology Co. Ltd (China).

June 2019 $ 5650 selected

Fluoroscopy Equipment Market by Product (Fixed C-arms, Fluoroscopy Systems (Remote Controlled), Mobile C-arms), and Application (Diagnostic (Cardiology, Gastroenterology), Surgical (Orthopedic, Cardiovascular) - Analysis & Global Forecast to 2024

The market for fluoroscopy equipment is expected to grow from USD 5.7 billion in 2019 to USD 7.1 billion by 2024, at a CAGR of 4.4% during the forecast period. Growth in the fluoroscopy equipment market is attributed to factors such as advantages of FPDs over image intensifiers, the use of fluoroscopy in pain management, reimbursement cuts for analog radiography systems, rising geriatric population, and the growing prevalence of chronic diseases. Major players operating in the fluoroscopy equipment market include Siemens Healthineers (Germany), GE Healthcare (US), Philips (Netherlands), Shimadzu Corporation (Japan), Ziehm Imaging (Germany), Canon Medical Systems (Japan), Hitachi (Japan), Carestream Health (US), Hologic (US), Lepu Medical Technology (China), Agfa-Gevaert Group (Belgium), and ADANI Systems (Belarus).

June 2019 $ 5650 selected

Bed Monitoring System & Baby Monitoring System Market by Type (Baby Monitor (Sensor & Wearable), Pressure Ulcer, Elderly Monitor (Fall Prevention), Sleep Monitor), End User (Home Care, Nursing Home & Assisted Living Facilities) - Global Forecast to 2024

The market for bed monitoring system & baby monitoring system is expected to grow from USD 1.3 billion in 2019 to USD 1.9 billion by 2024, at a CAGR of 7.9% during the forecast period. The report covered sensor pads or smart mattresses embedded with the sensors for bedsore monitoring, baby monitoring, elderly monitoring, and sleep monitoring. The growth of this market is driven primarily by factors such as growing investments in healthcare infrastructural development, increasing elderly population, rising adoption of unobtrusive monitoring solutions, increasing focus on reducing the treatment cost of pressure ulcer & fall injuries and increasing online availability & purchase of products. However, lack of awareness and acceptance of the products in developing countries is expected to restrain the growth of this market during the forecast period. The prominent players in this market include Early Sense (US), EMFIT (Finland), Eight Sleep (US), Smart Caregiver Corporation (US), Wellsense (US), Tekscan (US), Lenovo Group (Hong Kong) and Sleep Number Corporation (US).

June 2019 $ 5650 selected

BRIC Diagnostic Imaging Equipment Market by Modality ((X-Ray Imaging (Digital, Analog), MRI (High & Low Field), CT (Conventional, CBCT), Nuclear Imaging (SPECT, Hybrid PET)), End User (Hospitals, Imaging Centers) - Global Forecast to 2024

The BRIC diagnostic imaging equipment market is projected to reach USD 8.3 billion by 2024 from USD 5.3 billion in 2019, at a CAGR of 9.2% during the forecast period. The major factors driving the growth of the BRIC diagnostic imaging equipment market include the rising burden of target diseases and increasing investments, funds, and grants for the modernization of imaging facilities. The major players in the market include GE Healthcare (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Carestream Health, Inc. (US), Hologic, Inc. (US), Hitachi, Ltd. (Japan), Allengers (India), CURA Healthcare (India), Neusoft Corporation (China), NP JSC Amico (Russia), SONTU Medical Imaging Equipment Co., Ltd. (China), FUJIFILM Holdings Corporation (Japan), and United Imaging Healthcare Co, Ltd. (China), among others.

May 2019 $ 5650 selected

Microfluidic Components Market by Product (Valve, Solenoid Valve, Check Valve, Nozzle, Tubing, Micropump, Microneedle, Shuttle Valve), Industry (Automotive, Aerospace & Defense, Healthcare, Consumer Electronics, Oil & Gas) - Global Forecast to 2024

The global microfluidic components market is projected to reach USD 53.7 billion by 2024 from USD 21.6 billion in 2019, at a CAGR of 20.0%. Growth in this market is driven by the growing demand for smart and intelligent flowmeters, sensors, and advanced pumps in high-end industries; technological advancements; increasing focus on data precision and accuracy; and the growing demand for miniature portable devices. The prominent players in the global microfluidic components market are Parker Hannifin Corporation (US), Vesta Automation Srl (Italy), Staiger GmbH & Co. KG (Germany), Metal Work S.p.A. (Italy), Camozzi Automation Spa Società Unipersonale (Italy), Fortive Corporation (US), Aignep s.p.a. (Italy), International Polymer Solutions (US), FIM Valvole Srl (Italy), Humphrey Products Corporation (US), The Lee Company (US), and Dolomite Microfluidics (UK).

May 2019 $ 5650 selected

Surgical Tourniquets Market by Type (Tourniquets Systems, Tourniquet Cuffs, Tourniquets Accessories), Applications, End User (Hospitals and Trauma Centers, Ambulatory Surgery Centers, Military) - Global Forecast to 2024

The surgical tourniquets market is projected to reach USD 509 million by 2024 from USD 347 million in 2019, at a CAGR of 8.0%. The increasing incidence of road accidents and falls has resulted in driving the demand for surgical tourniquets. Moreover, rising aging population, and the growing number of joint replacement surgeries are the major factors responsible for the growth of this market. Emerging markets such as China, India, and Japan are the key areas of opportunity for players in this market. However, a dearth of trained professionals will limit market growth to a certain extent. Prominent players in the surgical tourniquets market are Stryker Corporation (US), Zimmer Biomet (US), ulrich medical (Germany), Hammarplast Medical (Sweden), Delfi Medical Innovations (Canada), VBM Medizintechnik (Germany), Pyng Medical (Canada), Zhangjiagang Huaxin Medical Equipment Factory (China), OHK Medical Devices (Israel), Daesung Maref (Korea), Hangzhou Zhengda Medical Co. (China), Dessillons & Dutrillaux (France), and AneticAid (UK).

May 2019 $ 5650 selected

Medical Device Contract Manufacturing Market by Device Type (IVD (Equipment, Consumable), Cardiovascular, Diabetes Care, Drug Delivery, Dental, Orthopedic, Ophthalmic, Endoscopy Devices) Class of Device (Class I, II III), Services - Global Forecast to 2024

The medical device contract manufacturing market is projected to reach USD 91.3 billion by 2024 from USD 55.0 billion in 2019, at a CAGR of 10.6%. The key factors driving the growth of the medical device contract manufacturing market include the overall growth of the medical devices market as a whole (mainly due to rising disease prevalence, life expectancy, and the geriatric population), increasing technological adoption in the medical devices industry leading to electronically integrated devices, and low returns on investment due to the rising cost of in-house manufacturing. Technological advancements have prompted end users to overhaul or update their manufacturing systems. As this is a costly process, they look forward to contract manufacturing. However, market growth is impeded by the growing consolidation in the medical devices market. The key players in the global medical device contract manufacturing market are Flex Ltd. (Singapore), Jabil Inc. (US), TE Connectivity, Ltd. (Switzerland), Sanmina Corporation (US), Nipro Corporation (Japan), Celestica Inc. (Canada), Plexus Corporation (US), Benchmark Electronics, Inc. (US), Integer Holdings Corporation (US), and Gerresheimer Ag (Germany).

May 2019 $ 5650 selected

Orthopedic Braces & Supports Market by Product (Knee, Ankle, Spine, Shoulder, Neck, Elbow, Wrist, Facial), Category (Soft, Hard), Application (Ligament (ACL, LCL), Preventive, OA), Distribution, and Region - Global Forecast to 2024

Orthopedic Braces & Supports Market by Product (Knee, Ankle, Spine, Shoulder, Neck, Elbow, Wrist, Facial), Category (Soft, Hard), Application (Ligament (ACL, LCL), Preventive, OA), Distribution, and Region - Global Forecast to 2024 The major players operating in the orthopedic braces and supports market are Bauerfeind AG (Germany), Össur Hf (Iceland), DJO Finance LLC (US), Breg, Inc. (US), and DeRoyal Industries, Inc. (US). Other prominent players operating in this market include Bird & Cronin, Inc. (US), medi GmbH & Co. KG (Germany), Ottobock Holding GmbH & Co. KG (Germany), BSN medical (Germany), Zimmer Biomet Holdings, Inc. (US), Oppo Medical, LLC (US), Becker Orthopedic (US), Thuasne Group (France), 3M Company (US), Reh4Mat (Poland), and United Ortho (US).

May 2019 $ 5650 selected

Sleep Apnea Devices Market by Type, (Therapeutic (CPAP, APAP, Masks, ASV, Oral Appliances, Mandibular Advancement Device)), Diagnostic (PSG, Oximeter), End User (Sleep Laboratories & Hospitals, Home Care Settings/Individuals) - Global Forecasts to 2024

The market for sleep apnea devices is expected to grow from USD 4.5 billion in 2019 to USD 7.5 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 10.7% during the forecast period. Growth in the sleep apnea devices market can be attributed to factors such the large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral appliances, technological advancements in sleep apnea devices, considerable venture capital funding, and the increasing number of companies venturing into sleep apnea and oral appliances markets. Major players operating in the sleep apnea devices market include ResMed (US), Koninklijke Philips (Netherlands), Fisher & Paykel Healthcare (New Zealand), SomnoMed (US), Oventus Medical (Australia), Compumedics (Australia), Löwenstein Medical (Germany), Drive DeVilbiss Healthcare (US), BMC Medical (China), Braebon Medical (Canada), and Panthera Dental (Canada).

May 2019 $ 5650 selected

Veterinary Rapid Test Market by Product (Rapid Test Kit, Rapid Test Readers), Application (Viral, Bacterial, Parasite, Allergies), and Animal Type (Companion (Cat, Dog, Horse), Livestock (Cattle, Swine, Poultry)) - Global Forecast to 2024

The global veterinary rapid tests market is projected to reach USD 854 million by 2024 from USD 573 million in 2019, at a CAGR of 8.3%. Factors contributing to the growth of this market include the increasing prevalence of zoonotic diseases among companion and livestock animals and the growing need for the rapid detection of these diseases. The prominent players in this market are Zoetis, Inc. (US), IDEXX Laboratories, Inc. (US), Heska Corporation (US), Biopanda Reagents Ltd. (UK), Fassisi GmbH (Germany), Virbac (France), BioNote, Inc. (South Korea), SWISSAVANS AG (Switzerland), MEGACOR Diagnostik GmbH (Austria), and Woodley Equipment Company (UK).

May 2019 $ 5650 selected

Breast Lesion Localization Methods Market by Type (Wire, Radioisotope [Radio Occult], Magnetic), Usage (Tumor Identification, Sentinel Lymph Node [Lumpectomy]), End User Preference Survey (Selection Criteria, Replacement Trend) - Global Forecast to 2024

The market for breast lesion localization methods is expected to grow from USD 413 million in 2018 to USD 598 million by 2024, at a CAGR of 6.3% during the forecast period. The growth of this market is primarily driven by factors such as the rising incidence of breast cancer, an increasing number of breast cancer surgeries, rising awareness of early detection of breast cancer. However, uncertainty in regulatory approval procedures is expected to restrain the growth of this market during the forecast period to a certain extent.BD (US), Endomagnetics (UK), SOMATEX Medical Technologies (Germany), Cook Medical (US), Cianna Medical (US), and Leica Biosystems (US).

May 2019 $ 5650 selected

Diagnostic Imaging Market by Product (MRI (Open, Closed), Ultrasound (2D, 3D/4D, Doppler), CT, X-Ray (Digital, Analog), SPECT, Hybrid PET, Mammography), Application (OB/Gyn, Cardiology, Oncology), End User (Hospitals, Imaging Centers) - Forecast to 2024

The global diagnostic imaging market is projected to reach USD 33.5 billion by 2024 from USD 25.7 billion in 2019, at a CAGR of 5.5% from 2019 to 2024. The major players in the market include GE Healthcare (US), Siemens Healthineers (Germany), Koninklijke Philips N.V. (Netherlands), Agfa-Gevaert N.V. (Belgium), Canon Medical Systems Corporation (Japan), Hitachi Ltd. (Japan), Carestream Health, Inc. (US), Esaote S.p.A (Italy), Hologic, Inc. (US), FUJIFILM Holdings Corporation (Japan), Samsung Electronics (South Korea), Mindray Medical International (China), Planmed Oy (Finland), CurveBeam LLC (US), Shimadzu Corporation (Japan) among others.

May 2019 $ 5650 selected

Fractional Flow Reserve Market by Technology (Invasive Monitoring, Non-invasive Monitoring), Invasive Monitoring Product (Pressure Guidewires, FFR Measurement Systems), Application, and Region - Global Forecast to 2024

The fractional flow reserve market is projected to reach USD 1,082 million by 2024 from USD 516 million in 2019, at a CAGR of 16.0% during the forecast period. Growth in this market is primarily attributed to the rising geriatric population and the subsequent growth in the prevalence of cardiovascular diseases, cost benefits of FFR, and the presence of a favorable reimbursement scenario for FFR. The key players in the fractional flow reserve market are Abbott (US), Boston Scientific (US), ACIST Medical Systems (US), Koninklijke Philips N.V. (Netherlands), Opsens, Inc. (Canada), HeartFlow, Inc. (US), Siemens Healthineers (Germany), Pie Medical Imaging (Netherlands), CathWorks (Israel), and Medis Medical Imaging Systems BV (Netherlands).

April 2019 $ 5650 selected

Companion Animal Diagnostics Market by Technology (Clinical Biochemistry, Urinalysis, Immunodiagnostic, Hematology, Molecular Diagnostics), Application (Clinical Pathology, Bacteriology, Parasitology), Animal (Dog, Cat), End User - Global Forecast to 2024

The companion animal diagnostics market is projected to reach USD 2.7 billion by 2024 from USD 1.7 billion in 2019, at a CAGR of 9.8%. The growth in this market is driven by the rising companion animal population, increasing demand for pet insurance, and the growth in the number of veterinary practitioners in developed countries. The growing demand for rapid tests and portable instruments for point-of-care services is expected to offer potential growth opportunities for market players in the coming years. The key players operating in the global companion animal diagnostics market are IDEXX Laboratories, Inc. (US), Zoetis, Inc. (US), Thermo Fisher Scientific, Inc. (US), Virbac (France), Heska Corporation (US), Neogen Corporation (US), bioMérieux SA (France), IDvet (France), INDICAL Bioscience GmbH (Germany) [QIAGEN N.V. (Netherlands)], and Randox Laboratories Ltd. (UK).

April 2019 $ 5650 selected

Central Fill Pharmacy Automation Market by Product (Equipment (Medication Dispensing System, Automated Medication Compounding Systems, Workflow Management), Service (Process Optimization, Facility Design), Software), Vendor - Global Forecast to 2024

The central fill pharmacy automation market is projected to reach USD 656 million by 2024 from USD 381 million in 2019, at a CAGR of 11.5%. The increasing demand for specialty drugs being dispensed by central fill pharmacies is one of the primary drivers propelling the growth of this market.ARxIUM, Inc. (US), RxSafe, LLC (US), TCGRX Pharmacy Workflow Solutions (US), Omnicell, Inc. (US), McKesson Corporation (US), ScriptPro (US), Kuka AG (Germany), Innovation (US), R/X Automation Solutions (US), Tension Packaging & Automation (US), Cornerstone Automation Systems, LLC (CASI, US), and QMSI (US).

April 2019 $ 5650 selected

Physiotherapy Equipment Market by Product (Laser Therapy, Ultrasound, Cryotherapy, Electrotherapy, and Accessories), Application (Musculoskeletal, Gynecology, Pediatric, Cardiovascular), and Region - Global Forecast to 2024

The physiotherapy equipment market is projected to reach USD 21.1 billion by 2024 from USD 15.1 billion in 2018, at a CAGR of 5.8%. The growth of this market is primarily driven by rapidly growing geriatric population and the subsequent increase in the global prevalence of chronic diseases, and growing incidence of sports injuries, degenerative joint disorders, and cerebrovascular disease. DJO Global (US), Performance Health (US), BTL Industries (US), and EMS Physio (UK).

April 2019 $ 5650 selected

Smoke Evacuation System Market by Product (Smoke Evacuator (Portable & Stationary), Filter, Pencil, Accessories), Application (General Surgery, Laparoscopic, Orthopedic, Aesthetic), End-User (Hospitals, ASC, Surgical Centers) - Global Forecast to 2024

The smoke evacuation systems market is estimated to grow at a CAGR of 6.6% to reach USD 223 million by 2024 from USD 162 million in 2019. Factors such increased product availability of smoke evacuation systems, rising patient preference for minimally invasive surgeries, expansion in the target patient population, and wider acceptance and availability of relevant operating room protocols and guidelines for smoke evacuation systems are the major factors driving the growth of the global smoke evacuation systems market. CONMED Corporation (US), Medtronic Plc (Ireland), Olympus (Japan), Ethicon (US), Erbe Elektromedizin GmbH (Germany), KLS Martin (Germany), Stryker Corporation (US), I.C Medical (US), Symmetry Surgical Inc. (US), Utah Medical Products Inc (US), Zimmer Biomet (US), Pall Corporation (US), Ecolab (US), and Deroyal (US) are some major players in the global smoke evacuation systems market.

April 2019 $ 5650 selected

Laboratory Proficiency Testing Market by Industry (Clinical Diagnostics (Routine Chemistry), Microbiology (Pathogens, Sterile Tests), Food, Animal Feed (Fish, Vegetable), Commercial Beverage (Alcohol), Water, Technology (PCR,)) - Global Forecast to 2024

The laboratory proficiency testing market is projected to reach USD 1,103 million by 2024 from USD 800 million in 2019, at a CAGR of 6.6% during the forecast period. PT forms an essential precondition for operational excellence and accreditation in several industries. This is one of the major factors driving the growth of the proficiency testing market, globally. Also, the stringent safety and quality regulations for food and pharmaceutical products and the increasing focus on water testing are the other major factors supporting market growth. However, the requirement of high capital investments for accurate and sensitive testing is expected to restrain the growth of this market during the forecast period. The prominent players operating in the global laboratory proficiency testing market are LGC Limited (UK), Bio-Rad Laboratories (US), Randox Laboratories (UK), Merck (Germany), College of American Pathologists (US), American Proficiency Institute (US), Waters Corporation (US), QACS (Greece), FAPAS (UK), AOAC (US), Phenova Inc. (US), Weqas (Cardiff), Advanced Analytical Solutions, LLC (UK), Bipea (France), Absolute Standards Inc. (US), and NSI Lab Solutions (US).

April 2019 $ 5650 selected

Cardiac Resynchronization Therapy Market by Product Type (Cardiac Resynchronization Therapy Defibrillator and Cardiac Resynchronization Therapy Pacemaker), End User (Hospitals & Cardiac Centers and Ambulatory Surgery Centers) - Global Forecast to 2024

The cardiac resynchronization therapy market is projected to reach $5.1 billion by 2024 from $4.1 billion in 2019, at a CAGR of 4.4%. The growth of the Cardiac Resynchronization Therapy Market is majorly driven by the increasing incidence of target diseases (primarily due to the rising geriatric population). Rising investments and support, along with technological advancements, are also contributing to the growth of this market. Prominent players in the Cardiac Resynchronization Therapy Market are Medtronic (Ireland), Abbott (US), Boston Scientific Corporation (US), MicroPort Scientific Corporation (China), BIOTRONIK (Germany), and Medico S.p.A. (Italy).

April 2019 $ 5650 selected

Elastography Imaging Market by Modality (Ultrasound, Magnetic Resonance Elastography), Application (Radiology, Cardiology, OB/GYN, Vascular, Orthopedic and Musculoskeletal), End User (Hospital, Surgery Center, Diagnostic Center) - Global Forecast to 2024

The market for elastography imaging is expected to grow from USD 2.5 billion in 2018 to USD 4.6 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 11.0 % during the forecast period. The growth of this market is mainly driven by the growing incidence of breast cancer and chronic liver diseases and a rising preference for minimally invasive procedures across the globe. However, the high cost of elastography imaging systems and an unfavorable reimbursement scenario are expected to restrain the growth of this market to a certain extent.

April 2019 $ 5650 selected

Inflation Device Market by Display Type (Analog & Digital), Capacity (20ml, 30ml, 60ml), Application (Interventional Cardiology, Radiology, Peripheral Vascular, Urology), End User (Hospitals & Clinics, Ambulatory Surgery Centers) - Forecasts to 2024

The global inflation devices market is projected to reach USD 600 Million by 2024 from USD 480 Million in 2019, at a CAGR of 4.7% from 2019 to 2024. The rising adoption of minimally invasive procedures, the presence of developed healthcare infrastructure in a majority of developed countries, the growing incidence of CVD, and the less-stringent approval procedures are contributing to the growth of the market. With the growth of the geriatric population, the prevalence of coronary artery disease is also expected to increase, which is a major target indication for interventional cardiology procedures that utilizes inflation devices to inflate and deflate the balloon. Aforementioned key factors are likely to fuel growth of inflation devices market over the forecast period. The major players operating in the inflation devices market are Merit Medical Systems (US), Boston Scientific Corporation (US), Cardinal Health (US), CONMED Corporation (US), Medtronic plc (Ireland), Acclarent Inc. (US), Cook Medical (US), Atrion Corporation (US), Becton, Dickinson and Company (US), Terumo Medical Corporation (Japan), B. Braun Melsungen AG (US), Olympus Corporation (Japan), Teleflex Incorporated (US), and US Endovascular (US), among others.

April 2019 $ 5650 selected

Over The Counter/OTC Test Market by Product (Glucose Monitoring Test, Cholesterol Monitoring Test, Infectious Disease Testing, Fecal Occult Test, Urine Analysis Test, Drug Abuse Test), Technology (Immunoassay, Lateral Flow Assay)-Global Forecast to 2024

The OTC tests market is projected to reach USD 22.2 billion by 2024 from USD 11.9 billion in 2018, at CAGR of 11.0% during the forecast period. The growth of the OTC tests market is mainly driven by the rising prevalence of target diseases and disorders, such as diabetes and infectious diseases, both prominent ailments across the globe that require rapid and effective testing.OraSure Technologies (US), Roche Diagnostics (Switzerland), and i-Health Lab (US).

April 2019 $ 5650 selected

Microcatheters Market by Type (Delivery, Diagnosis, Aspiration, Steerable), Design (Single, Dual Lumen), Application (Cardiovascular, Neurovascular, Peripheral Vascular, Oncology, Urology), End-User (Hospital, Specialty Clinics) - Global Forecasts to 2024

The global microcatheters market is projected to reach USD 924 Million by 2024 from USD 688 Million in 2018, at a CAGR of 5.0% from 2018 to 2024. The growth of this market is primarily driven by majorly driven by the growth in the target patient population (suffering from cardiovascular diseases, neurovascular disorders, and cancer), rising adoption of minimally invasive surgical procedures, and the increasing number of microcatheter-assisted clinical research studies. The major players operating in the microcatheters market are Boston Scientific Corporation (US), Medtronic Plc (Ireland), Terumo Corporation (Japan), ASAHI INTECC CO., LTD. (Japan), and MERIT MEDICAL SYSTEMS, INC. (US). The other prominent players operating in the overall microcatheters market include, Teleflex Incorporated (US), Johnson and Johnson (US), Stryker Corporation (US), Cook Group Incorporated (US), Cardinal Health, Inc. (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), AngioDynamics, Inc. (US), Penumbra, Inc (US), and BTG PLC (UK), among others.

April 2019 $ 5650 selected

Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, PoC Analyzers), Application (UTI, Diabetes, Pregnancy), End User (Hospital, Labs, Homecare) & Test Type - Global Forecast to 2024

The global urinalysis market is projected to reach USD 4.6 billion by 2024 from USD 3.2 billion in 2019, at a CAGR of 7.6% from 2019 to 2024. Integrated systems for urinalysis and the emerging economies are expected to provide a wide range of growth opportunities for players in the market which is driven by growing incidences of UTI and other kidney diseases.Seimens Healthineers (Germany), Roche Diagnostics (Switzerland), Cardinal Health (US), Arkray Inc (Japan), Sysmex Corporation (Japan), Alere Inc. (US), Beckman Coulter (US), Bio-Rad Laboratories (US), 77 Elektronika Kft (Hungary), and DIRUI (China), ACON Laboratories (US), Quidel Corporation (US) and URIT Medical Electronic Ltd. (China).

March 2019 $ 5650 selected

North American Radiation Protection Apron Market by Type (Front Protection, Vest and Skirt, Pregnancy Lead Apron), Material (Lead Aprons, Lead-Free Apron, Light Lead Composite Apron), Country (US, Canada) - North America - Forecast to 2024

The North American medical radiation protection aprons market is projected to reach USD 49 million by 2024 from USD 36 million in 2019, at a CAGR of 6.6% during the forecast period. Growth in this market is driven by the increasing safety awareness among people working in radiation-prone environments, growth in the number of trained radiologic technologists, growing number of orthopedic and spine surgeries, and the increasing prevalence of cancer. On the other hand, discomfort and pain due to the heavy weight of lead aprons is expected to hamper the growth of this market during the forecast period. Prominent players in the medical radiation protection aprons market include Infab Corporation (US), Bar·Ray Products (US), Burlington Medical LLC (US), Shielding International, Inc. (US), and AliMed, Inc. (US).

March 2019 $ 5650 selected

Interventional Oncology Market by Product (Radiofrequency, microwave, cryoablation, embolization, guidewires), Procedures (Thermal Ablation, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung, Kidney, Bone Metastasis) - Global Forecast to 2024

The global interventional oncology market is projected to reach USD 2.9 billion by 2024 from USD 2.0 billion in 2019, at a CAGR of 6.8% from 2019 to 2024. The growth of this market is primarily driven by the rising preference for minimally invasive procedures, expansion of the target patient population, increasing public-private funding and government support for cancer research, technological advancements in the field of interventional oncology, and increasing government investments and funding for interventional oncology and related cancer research. The major players operating in the interventional oncology market are Medtronic (Ireland), Boston Scientific (US), BTG plc (UK), Merit Medical Systems (US), and Terumo (Japan). The other prominent players operating in the overall interventional oncology market include AngioDynamics (US), Ethicon (part of J&J) (US), Teleflex (US), Cook Medical (US), HealthTronics (US), MedWaves Medical (US), Sanarus (US), IMBiotechnologies (Canada), Trod Medical (US), IceCure Medical (Israel), Mermaid Medicals (Denmark), and Interface Biomaterials BV (Netherlands).

March 2019 $ 5650 selected

Dental Consumables Market by Product (Implants, Prosthetics, Orthodontics, Endodontics, Infection Control, Periodontics, Whitening Products, Prophylaxis, Fluorides, Sealants, Splints), End-User (Hospital & Clinic, Laboratory) - Global Forecast to 2024

The global dental consumables market is projected to reach USD 38.7 billion by 2024 from USD 27.9 billion in 2019, at a CAGR of 6.8% during the forecast period. The rising incidence of dental diseases, increasing demand for cosmetic dentistry, growing dental tourism, and the increasing disposable income in developing countries are the major factors driving the growth of this market. The prominent players operating in the dental consumables market include Straumann Holding AG (Switzerland), Danaher Corporation (US), Dentsply Sirona (US), 3M Company (US), Henry Schein, Inc. (US), Kuraray Co., Ltd. (Japan), Geistlich Pharma AG (Switzerland), Ivoclar Vivadent AG (Liechtenstein), GC Corporation (Japan), Mitsui Chemicals Inc. (Japan), Keystone Dental, Inc. (US), BEGO GmbH & Co. KG (Germany), Young Innovations Inc. (US), and Septodont Holding (France).

March 2019 $ 5650 selected

Medical Equipment Cooling Market by Type (Liquid & Air-based Cooling), Compressor (Scroll, Screw, Centrifugal, Reciprocating), Configuration (Packaged, Modular, Split), Application (MRI, CT, PET, LINAC, Medical Lasers), End User (OEMS, Hospitals & Labs, Diagnostic Treatment Centers & Laboratories) - Global Forecast to 2024

The medical equipment cooling market is projected to grow from an estimated USD 233 million in 2024 to USD 193 million by 2019, at a CAGR of 3.8% during the forecast period. Market growth of the medical equipment cooling market is mainly driven by the economic benefits offered by cooling systems, rising incidence of cancer and other diseases, and growing geriatric population. The global medical equipment cooling market is projected to reach USD 233 million by 2024 from USD 193 million in 2019, at a CAGR of 3.8%.

March 2019 $ 5650 selected

Medical Vacuum System Market by Product (Standalone, Centralized, Portable), Technology (Dry Claw, Oil Sealed Rotary Vane, Liquid Ring), Application (Diagnostic, Wound Care, GYN), End user (Pharmaceutical, Diagnostic Labs) - Global Forecast to 2024

The Medical Vacuum System Market is estimated to grow at a CAGR of 6.3% to reach USD 1.6 billion by 2024 from USD 1.1 billion in 2018. Factors such technological advancements in vacuum systems, stringent regulatory frameworks mandating the use of vacuum systems, the increasing number of target surgical procedures across major markets, and the rising number of diagnostic imaging procedures are driving the growth of the global medical vacuum systems market. Atlas Copco AB (Sweden), Gardner Denver Holdings (US), Busch Holding GmbH (Germany), Drägerwerk AG & Co. KGaA (Germany), Asahi Kasei ZOLL Medical Corporation (Japan), Olympus Corporation (Japan), ConvaTec (UK), INTEGRA Holdings (US), Allied Healthcare Products Inc. (US), Medela AG (Switzerland), Air Techniques (US), Laerdal Medical (Norway), Precision Medical, Inc. (US), Medicop (Slovenia), and Ohio Medical Corporation (US) are some major players in the global medical vacuum systems market.

March 2019 $ 5650 selected

Pharmaceutical Drug Delivery Market by Route (Oral (Tablet), Pulmonary (Nebulizer), Injectable, Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal), Application (Cancer, Diabetes), Patient Care Setting (Hospital) - Global Forecast to 2023

The global pharmaceutical drug delivery market is projected to reach USD 1,694.7 billion by 2023 from USD 1,244.4 billion in 2018, at a CAGR of 6.4% during the forecast period. Growth in this market is mainly driven by the rising prevalence of chronic diseases, growth in the biologics market, and technological advancements and new product launches. The global pharmaceutical drug delivery market is highly competitive owing to the presence of several large and small players. Johnson & Johnson, Inc. (US), F. Hoffman-La Roche (Switzerland), Merck & Co., Inc. (US), Bayer AG (Germany), Pfizer, Inc. (US), Novartis AG (Switzerland), 3M Company (US), Becton, Dickinson and Company (US), GlaxoSmithKline plc, (UK), Sanofi (France), and Antares Pharma, Inc. (US) are some of the leading players operating in the pharmaceutical drug delivery market.

March 2019 $ 5650 selected

Peripheral Vascular Devices Market by Type (Angioplasty Balloon, Stent, Catheters (Angiography, IVUS), Plaque Modification (Atherectomy, Thrombectomy), Hemodynamic Flow Alteration (Embolic Protection), IVC Filters, Guidewires) - Global Forecast to 2024

The peripheral vascular devices market is projected to reach USD 14.4 billion by 2024 from USD 10.3 billion in 2019, at a CAGR of 6.8% during the forecast period. Growth in this market is driven by the rising global prevalence of peripheral artery diseases, increasing geriatric population, and rising prevalence of diabetes. On the other hand, the availability of alternative treatments and product failures and recalls are the major factors that are expected to restrain the growth of this market during the forecast period. Some of the major players in the peripheral vascular devices market include Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), Cardinal Health (US), iVascular (Spain), Becton, Dickinson and Company (US), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Biosensors International Group (Singapore), and BIOTRONIK SE & Co. KG (Germany).

February 2019 $ 5650 selected

Closed System Transfer Devices Market by Closing Mechanism (Luer-Lock, Push-to-Turn), Type (Membrane-to-Membrane, Needleless), Technology (Diaphragm, Compartmentalize, Air Filtration), Component, End User (Hospital, Clinic) - Global Forecast to 2024

The closed system transfer devices market is projected to reach USD 982 million by 2024 from USD 390 million in 2019, at a CAGR of 20.3%. Growth in this market is mainly driven by the rising prevalence of cancer, increasing number of oncology drug approvals, increasing use of closed system transfer devices to combat the harmful effects of cytotoxic or antineoplastic drugs, and improving regulatory guidelines regarding the safe handling and use of hazardous drugs. Prominent players in the closed system transfer devices market are Becton, Dickinson and Company (US), ICU Medical, Inc. (US), Equashield LLC. (US), B. Braun Melsungen AG (Germany), Corvida Medical (US), Yukon Medical (US), JMS Co., Ltd. (US), CODAN Medizinische Geräte GmbH & Co KG (Germany), Baxter International, Inc. (US), VICTUS (US), and Caragen Ltd. (Ireland).

February 2019 $ 5650 selected

Near Infrared Imaging Market by Product Type (NIR Fluorescence Imaging, Reagents), Application (Cancer surgery, Plastic surgery, Gastrointestinal surgery) End Users (Hospitals & Clinics, Research laboratory, Pharmaceutical companies) - Global Forecast to 2023

The near-infrared imaging market is projected to reach USD 822 million by 2023 from an estimated USD 416 million in 2018, at a CAGR of 14.6% during the forecast period. Growth in the near-infrared imaging market can primarily be attributed to the increasing number of surgical procedures globally and the advantages of NIR imaging over conventional visualization methods. The key players operating in the near-infrared imaging market are Stryker (US), KARL STORZ SE & Co. KG (Germany), Carl Zeiss Meditec AG (Germany), Leica Microsystems (Germany), Olympus (Japan), Fluoptics (France), Hamamatsu Photonics K.K (Japan), Quest Medical Imaging B.V. (Netherlands), Mizuho Medical Co, Ltd. (Japan), Shimadzu Corporation (Japan), Visionsense (Israel), PerkinElmer, Inc. (US), LI-COR, Inc. (US), and SurgVision (Netherlands).

February 2019 $ 5650 selected

Infection Control Market by Product (Disinfection (Disinfectant, Wipes, Sprays, Liquids, Disinfectors, UV, Wraps), AER, Sterilization (Steam, Hydrogen Peroxide, Radiation, Indicators, Services), End User (Hospitals, Life Science)) - Global Forecast to 2024

The infection control market is projected to reach USD 27.5 billion by 2024 from USD 20.0 billion in 2019, at a CAGR of 6.6% during the forecast period. The infection control market is largely driven by the high incidence of HAIs and SSIs; the increasing number of surgical procedures worldwide, the rapidly growing pharmaceutical, life science and medical device industry; and the growing need for food sterilization. Some major players operating in this market include Getinge AB (Sweden), STERIS plc. (US), Advanced Sterilization Products (US), 3M Company (US), Belimed AG (Switzerland), Cantel Medical Corporation (US), MMM Group (Germany), Matachana Group (Spain), Sotera Health LLC (US), Ecolab, Inc. (US), Metrex Research Corporation (US), Reckitt Benckiser Group Plc. (UK), Miele Group (Germany), Melag (Germany), and Pal International (UK).

February 2019 $ 5650 selected

Pen Needles Market by Type (Standard Pen Needles and Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone, and Others), Mode of Purchase (Retail, Non-Retail) - Global Forecasts to 2023

The pen needles market is expected to reach USD 3.4 billion by 2023 from an estimated USD 2.0 billion in 2018, at a CAGR of 11.0% during the forecast period. Growth in the pen needles market is mainly driven by factors such as the growing prevalence of chronic diseases and the favorable reimbursement scenario in selected countries. The growing preference for biosimilar drugs is another factor providing a wide range of growth opportunities for key players in the market. The key players in the pen needles market are Becton, Dickinson and Company (US), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), HTL-STREFA S.A. (Poland), Terumo Corporation (Japan), and Owen Mumford (UK).

February 2019 $ 5650 selected

Ligation Devices Market by Product (Hand-held Instruments, Accessories), Procedure (Minimally Invasive & Open Surgery), Application (Gynaecology, GIT, Cardiothoracic, Urology), End User (Hospital, Nursing Homes) - Global Forecast to 2024

The ligation devices market is projected to reach USD 1,189 million by 2024 from USD 876 million in 2019, at a CAGR of 6.3% during the forecast period. Growth in this market is mainly driven by the increasing prevalence of diseases requiring surgical treatment, especially minimally invasive surgery (MIS). However, the high cost of ligation devices is a major restraint for this market, particularly in emerging countries. Some of the major players in this market include Ethicon (Johnson and Johnson) (US), Teleflex Incorporated (US), Olympus (Japan), Applied Medical (US), ConMed (US), Cooper Surgical (US), Genicon (US), Grena Think Medical (UK), B.Braun (Germany), and Medtronic (Ireland).

February 2019 $ 5650 selected

Molecular Quality Controls Market by Product (Independent, Instrument Specific (DNA Sequencing)), Analyte Type (Single Analyte, Multianalyte), Application (Infectious Diseases), End User (IVD Manufacturers, Research Institute) - Global Forecast to 2024

The market for molecular quality controls is expected to grow from USD 132 million in 2018 to USD 237 million by 2024, at a CAGR of 10.2% during the forecast period. The growth of this market is primarily driven by factors such as the growing adoption of third-party quality controls, increasing number of accredited clinical laboratories, and the rising demand for external quality assessment support. The prominent players in the molecular quality controls market are SeraCare Life Sciences Inc. (US), ZeptoMetrix Corporation (US), Bio-Rad Laboratories Inc. (US), Microbiologics Inc. (US), and Thermo Fisher Scientific (US).

February 2019 $ 5650 selected

Specimen Retrieval Market by Bag Size (5, 10, 15, 25 mm), Type (Detachable, Non-detachable), Application (Gynecology, Urology, Gastrointestinal Surgery), End User (Hospitals, Ambulatory Surgical Centers, Nursing Home) - Global Forecast to 2024

The specimen retrieval systems market is projected to reach USD 290 million by 2024 from USD 230 million in 2019, at a CAGR of 4.7% during the forecast period. Growth in this market is mainly driven by the increasing prevalence of diseases requiring surgical treatment, especially laparoscopic surgeries. However, the high cost of specimen retrieval systems is a major challenge for this market, particularly in emerging countries. Some of the major players in this market include Johnson & Johnson Services, Inc. (US), Teleflex Incorporated (US), Applied Medical Resources Corporation (US), CONMED Corporation (US), Cooper Surgical, Inc. (US), Genicon (US), B. Braun Melsungen AG (Germany), Laprosurge (UK), Purple Surgical (UK), and Medtronic (Ireland).

February 2019 $ 5650 selected

Immuno Oncology Assays Market by Product (Consumables, Software), Technology (Immunoassay, Flow Cytometry, PCR, Next Generation Sequencing), Indication (Lung Cancer, Colorectal Cancer), Application (Research, Clinical Diagnostics) - Global Forecast to 2024

The market for immuno-oncology assays is expected to reach USD 5.9 billion by 2024 from USD 2.9 billion in 2018, at a CAGR of 12.7% during the forecast period. The growth of this market is primarily driven by factors such as the increasing adoption of targeted therapy over traditional therapy and increasing demand for mAbs. However, the high cost of immunotherapy treatment and the high attrition rate in the product development cycle are the major factors that are expected to restrain the growth of this market during the forecast period. The key players operating in the immuno-oncology assays market are Thermo Fischer Scientific (US), Roche Diagnostics (Switzerland), Agilent Technologies (US), and Illumina (US). A majority of the leading players in the market focus on both organic and inorganic growth strategies such as collaborations, partnerships, acquisitions, and agreements to maintain and enhance their market shares in the immuno-oncology assays market.

February 2019 $ 5650 selected

Spirometer Market by Product (Device, Consumables, Accessories, Software), Mechanism (Flow Sensor, Peak Flow Meters), Application (COPD, Asthma), End User (Hospital, Clinical Laboratories, Home care, Industrial Settings) - Global Forecast to 2023

The spirometers market is projected to reach USD 1,047 million by 2023 from USD 655 million in 2018, at a CAGR of 9.8% during the forecast period. Growth in this market is driven by the rising global incidence of chronic respiratory diseases, increasing global aging population, and technological shifts in spirometer devices toward smartphone-based data connectivity. On the other hand, the time required to carry out tests is expected to limit market growth during the forecast period. Some of the major players in this market include Hill-Rom (US), Vyaire Medical (US), Fukuda Sangyo (Japan), Chest MI (Japan), Schiller AG (Switzerland), MGC Diagnostics (US), Medical International Research (Italy), NDD Medical Technologies (Switzerland), Vitalograph (UK), and MidMark Corporation (US).

February 2019 $ 5650 selected

X-Ray Detector Market by Type (FPD, CSI, Gadox, CCD, Line scan), Panel (Small, Large), Portability (Fix, Portable), System (New, Retrofit), Application (Medical, Orthopedic, Mammogram, Dental, Cardiac, Veterinary, Security) - Global Forecast to 2024

The X-ray detectors market is projected to reach USD 3.8 billion by 2024 from USD 2.8 billion in 2019, at a CAGR of 6.1%. Factors such as growing public and private investments in digital imaging technologies, declining prices and benefits offered by digital detectors, and reimbursement cuts for analog X-rays are driving the growth of the X-ray detectors market. The introduction of wireless X-ray detectors, growing medical tourism in developing countries, and the emerging markets are expected to provide a wide range of growth opportunities for players in this market during the forecast period. However, the high cost of digital X-ray systems is expected to restrain the growth of this market. The X-ray detectors market is highly competitive with the presence of several small and big players. Some of the prominent players in the X-ray detectors market include Varex Imaging Corporation (US), Thales Group (France), Canon, Inc. (Japan), Konica Minolta, Inc. (Japan), Teledyne DALSA Inc. (US), Fujifilm Holdings Corporation (Japan), Agfa-Gevaert Group (Belgium), Carestream Health (US), Vieworks Co., Ltd (South Korea), Analogic Corporation (US), Rayence (South Korea), and Hamamatsu Photonics K.K. (Japan).

February 2019 $ 5650 selected

Digital Diabetes Management Market by Product (Device (Smart Glucometer, CGM, Insulin Pump & Patch), Diabetes Apps, Service, Data Management Software), Device Type (Hand-held & Wearables),End User (Hospitals & Self/home healthcare) - Global Forecast to 2024

The global digital diabetes management market is projected to reach USD 19.9 billion by 2024 from USD 6.8 billion in 2019, at a CAGR of 23.8%. The growth of this market is mainly driven by the rising prevalence of diabetes, increasing focus on the development and adoption of digital platform for diabetes, and technological advancements. Prominent players in the digital diabetes management market are Medtronic (Ireland), B. Braun (Germany), Dexcom (US), Abbott Laboratories (US), Roche Diagnostics (Switzerland), Insulet Corporation (US), Tandem Diabetes Care (US), Ascensia Diabetes Care (Switzerland), LifeScan (US), Tidepool (US), AgaMatrix (US), Glooko Inc. (US), and DarioHealth (Israel).

January 2019 $ 5650 selected

Breast Imaging Market by Technology (Ionizing (Mammography (Digital Mammography, 3D Mammogram, Analog), MBI, PET-CT, PEM), Non-ionizing (Breast Ultrasound, Breast MRI, Automated Whole-Breast Ultrasound, Breast Thermography)) - Global Forecast to 2023

The Breast Imaging Market is projected to grow from an estimated USD 3.1 billion in 2018 to USD 4.6 billion by 2023, at a CAGR of 8.0% during the forecast period. Market growth is largely driven by factors such as technological advancements, the rising prevalence of breast cancer, the increasing number of screening programs as well as rising number of conferences and symposiums focusing on spreading awareness about the benefits of early screening and diagnosis. The emerging markets, growing government and private investments to meet the increasing demand for breast cancer screening, and the improving reimbursement scenario are expected to present a wide range of growth opportunities for market players. The major players operating in the breast imaging market are Hologic, Inc. (US), GE Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare (Netherlands), FUJIFILM Holdings Corporation (Japan), Aurora Imaging Technology, Inc. (US), Canon Inc. (Japan), CMR Naviscan Corporation (US), Delphinus Medical Technologies, Inc. (US), Dilon Technologies, Inc. (US), KUB Technologies Inc. (Kubtec) (US), Micrima Limited (UK), Planmed Oy (Finland), SonoCiné, Inc. (US), and SuperSonic Imagine (France).

January 2019 $ 5650 selected

US Outpatient Surgical Procedures Market by Surgical Procedure Type (Gastrointestinal, Cardiovascular, Neurological, Orthopedic, Gynecologic, Integumentary, Ophthalmic), Patient Care Setting (Physician's Office, Hospital OPDs, ASCs) - US Forecast to 2023

The number of outpatient surgical procedures in the US is expected to grow from ~129 million procedures in 2018 to ~144 million procedures by 2023, at a CAGR of 2.1% during the forecast period. The growing number of outpatient surgeries is expected to increase the adoption of capnography monitoring devices in outpatient surgical departments in the US.

January 2019 $ 5650 selected

Radiotherapy Market by Type (External (IGRT, IMRT, 3D-CRT, Stereotactic), Brachytherapy (LDR, HDR)), Product (LINAC, CyberKnife, Gamma Knife, Tomotherapy, Particle Therapy, Cyclotron), Application (Prostate, Breast), End User (Hospital) - Forecasts to 2023

The radiotherapy market is projected to grow from an estimated USD 5.6 billion in 2018 to USD 6.8 billion by 2023, at a CAGR of 4.1% during the forecast period. Market growth is largely driven by factors such as technological advancements, the rising prevalence of cancer, the increasing number of conferences and symposia focusing on spreading awareness about the benefits of radiotherapy, and the growing use of particle therapy for cancer treatment. The emerging markets, growing government and private investments to meet the increasing demand for cancer treatment, and the improving reimbursement scenario are expected to present a wide range of growth opportunities for market players. The major players operating in the radiotherapy market are Varian Medical Systems, Inc. (US), Elekta (Sweden), Accuray Incorporated (US), Ion Beam Applications SA (Belgium), ViewRay, Inc. (US), IsoRay Medical, Inc. (US), Hitachi Ltd. (Japan), Panacea Medical Technologies Pvt. Ltd. (India), Provision Healthcare (US), Mevion Medical Systems, Inc. (US), Sumitomo Heavy Industries, Ltd. (Japan), Optivus Proton Therapy, Inc. (US), P-cure Ltd. (Israel), Theragenics Corporation (US), and C.R.Bard, Inc. (US).

January 2019 $ 5650 selected

Dental Biomaterials Market by Type (Metallic (Titanium, Stainless Steel, Chromium Alloy, Amalgam, Gold), PFM, Ceramic, Bone Graft, Polymer Biomaterials), Application (Implantology, Prosthetic, Orthodontic), End User - Global Forecast to 2023

The global dental biomaterials market is projected to reach USD 9.6 billion by 2023 from USD 6.7 billion in 2018, at a CAGR of 7.4%. The growing prevalence of dental disorders, rising geriatric population, and the growing dental tourism in emerging countries are the major factors driving the growth of this market. On the other hand, the presence of stringent regulatory and clinical processes is one of the major factors restraining market growth. The prominent players in the dental biomaterials market include Institut Straumann AG (Switzerland), Geistlich Pharma AG (Switzerland), Zimmer Biomet Holdings, Inc. (US), Danaher Corporation (US), Dentsply Sirona, Inc. (US), 3M Company (US), Royal DSM (Netherlands), Carpenter Technology Corporation (US), Kuraray Co., Ltd (Japan), Medtronic Plc. (Ireland), Henry Schein, Inc. (US), Mitsui Chemicals ,Inc. (Japan), Victrex Plc (UK), Ivoclar Vivadent AG (Principality of Liechtenstein), GC Corporation (Japan), Keystone Dental, Inc. (US), Datum Dental Ltd (Israel), BEGO Medical GmbH (Germany), and Cam Bioceramics B.V (Netherland).

January 2019 $ 5650 selected

Transdermal Drug Delivery System Market by Type (Patches and Semisolid formulations), Applications (Pain Management, Central Nervous System Disorders, Hormonal Applications, Cardiovascular Diseases), End User, and Region - Global Forecast to 2023

The report "", The transdermal drug delivery systems market is expected to reach USD 7.1 billion by 2023 from an estimated USD 5.7 billion in 2018, at a CAGR of 4.5% during the forecast period. The growth of this market is primarily driven by factors such as the increase in the prevalence of chronic diseases and technological advancements in transdermal drug delivery systems. The key players in the transdermal drug delivery systems market are Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), Novartis (Switzerland), GlaxoSmithKline (UK), Boehringer Ingelheim (Germany), Johnson & Johnson (US), Endo International (Ireland), and Purdue Pharma (US).

January 2019 $ 5650 selected



<< < 1

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us


Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 

Live Chat Support



US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



M&M Custom Research Services provides clients with the information on their business scenario required to stay ahead of competition in today's fast paced business environment.
'Connect With Us

Call us at: 1-888-600-6441
Live Chat Support


Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo